Predictive value of hematologic parameters and clinicopathological features of poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma-Reference-Cited by-同舟云学术

Predictive value of hematologic parameters and clinicopathological features of poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma

Published:2024-08-06 Issue:1 Volume:409 Page:
ISSN:1435-2451
Container-title:Langenbeck's Archives of Surgery
language:en
Short-container-title:Langenbecks Arch Surg

Author:

Huang Dongmei,Zhang Jinming,Zheng Xiangqian,Gao Ming

Funder

the National Natural Science Foundation of China

Tianjin Municipal Science and Technology Project

The Science &Technology Development Fund of Tianjin Education Commission for Higher Education

Tianjin Key Medical Discipline (Specialty) Construction Project

Tianjin Health Research Project

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00423-024-03431-8.pdf

Reference51 articles.

1. Xu B, Ghossein R (2020) Poorly differentiated thyroid carcinoma. Semin Diagn Pathol 37:243–247

2. Bible KC, Kebebew E, Brierley J et al (2021) 2021 American Thyroid Association Guidelines for Management of patients with anaplastic thyroid Cancer. Thyroid: Official J Am Thyroid Association 31:337–386

3. Acquaviva G, Visani M, Repaci A et al (2018) Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance. Histopathology 72:6–31

4. Hiltzik D, Carlson DL, Tuttle RM et al (2006) Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 106:1286–1295

5. Besic N, Hocevar M, Zgajnar J et al (2005) Prognostic factors in anaplastic carcinoma of the thyroid-a multivariate survival analysis of 188 patients. Langenbeck’s Archives Surg 390:203–208